Showing results (291-300 of 465) with videos related to

Sort By:
Pageof 47
Ophthalmology. Glaucoma|May 2, 2020
Prioritizing outcome preferences in patients with ocular hypertension and open-angle glaucoma using best-worst scalingJimmy T Le, Amanda K Bicket, Ellen M Janssen, et al.
Journal of Scleroderma and Related Disorders|November 15, 2024
A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ studyDinesh Khanna, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, et al.
Expert Review of Clinical Immunology|October 20, 2020
The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patientsFrancesco Benvenuti, Elisabetta Zanatta, Jérôme Avouac, et al.
Journal of the Endocrine Society|July 23, 2025
Low Testosterone Among Males in Opioid Agonist Therapy and Its Association With Fatigue and Psychological DistressJørn Henrik Vold, Elinor Chelsom Vogt, Anne Taraldsen Heldal, et al.
ERJ Open Research|June 1, 2023
Clinical trial simulations in pulmonary fibrosis: patient-focused insights and adaptationsSteve Jones, Maxine Flewett, Ron Flewett, et al.
Foodborne Pathogens and Disease|March 26, 2008
Outbreak of Salmonella Thompson infections linked to imported rucola lettuceKarin Nygård, Jørgen Lassen, Line Vold, et al.
The Lancet. Rheumatology|January 24, 2024
Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controlled trialsAnna-Maria Hoffmann-Vold, Elizabeth R Volkmann, Yannick Allanore, et al.
Rheumatology (Oxford, England)|May 31, 2022
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung diseaseMichael Kreuter, Anna-Maria Hoffmann-Vold, Marco Matucci-Cerinic, et al.
Scientific Reports|September 23, 2015
Visualization of expanding warm dense gold and diamond heated rapidly by laser-generated ion beamsW Bang, B J Albright, P A Bradley, et al.
BMJ Open|August 28, 2020
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, et al.
Pageof 47